cyclo(glutamyl- alanyl- isoleucyl- leucyl- tryptophyl)

endothelin A receptor antagonist from Streptomyces misakiensis

Also Known As:

BE 18257B; BE-18257B; WS 7338B; WS-7338B; cyclo(Glu-Ala-Ile-Leu-Trp); cyclo(Ile-Leu-Trp-Glu-Ala); cyclo(isoleucyl-leucyl-tryptophyl-glutamyl-alanyl); Cyclo(L-alanyl-D-alloisoleucyl-L-leucyl-D-tryptophyl-D-alpha-glutamyl)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl): 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl): 1

Related Diseases

1.	Ischemia 11/01/1995 - "We measured plasma ET-1 concentrations by radioimmunoassay in isolated blood-perfused neonatal lamb hearts before and after 2 hours of 10 degrees C cardioplegic ischemia and examined the effects of ET-1 and the endothelin-A (ET-A) receptor antagonist BE-18257B on the postischemic recovery of isolated hearts. "

Related Drugs and Biologics

1.	Endothelins (Endothelin)